However, on Day 180, the MMD patients had significantly lower levels of cortisol (p = 0.01), FGF-2 (p < 0.001), IL-8 (p < 0.001), MCP-1 (p = 0.005), and TGF-a (p = 0.04) compared to their MHD counterparts. This evidence concerns the gene FGF2 and multiminicore myopathy.